XC Interspinous Spacer II (Titanium)

Lumbar spinal stenosis with neurogenic claudication is the primary clinical setting for this device, used in patients who have not responded adequately to conservative treatment but may not be suitable candidates for, or may wish to avoid, more invasive decompression or fusion surgery at the affected level. Procurement governance matters as much as clinical fit: NHS spine units evaluating minimally invasive stenosis treatment options need the correct interspinous spacer reference confirmed and reliably stocked, which is why resolving the relationship between XC's two similarly named products matters before tender submission.

Patients with significant medical comorbidities form a second clinical setting, where general clinical literature notes that the minimally invasive nature of interspinous spacer implantation, in some cases performed under local anaesthesia, may suit patients less able to tolerate open surgery or general anaesthesia and its associated risks.

Cases requiring finer size graduation at the smaller end of the range represent a third clinical setting, where this reference's 1mm steps between 8mm, 9mm, and 10mm may support more precise sizing than the 2mm steps confirmed on XC's other interspinous spacer product at the equivalent range.

Patients seeking a treatment option between conservative care and open surgery make up a fourth clinical setting, where general clinical literature positions interspinous spacers as addressing a gap in the continuum of care for moderate lumbar spinal stenosis. Medigear.uk supports single or small-quantity ordering of this device alongside the bulk distributor accounts it also serves, so a specialist clinic is not required to commit to trust-scale volumes to access it.

Finer Size Graduation at the Smaller End

Confirmed 1mm steps between 8mm, 9mm, and 10mm offer finer sizing than the 2mm steps confirmed on XC's other interspinous spacer product across the equivalent range.

Genuinely Distinct, Well-Established Device Category

Interspinous spacers are a well-documented device category in spine surgery, with a substantial published evidence base including randomised trials, distinct from the fusion and interbody devices covered elsewhere in this catalogue.

Minimally Invasive Implantation

General clinical literature describes interspinous spacer implantation as less invasive than direct decompression procedures such as laminectomy, in some cases performed under local anaesthesia in an ambulatory setting.

Transparently Flagged Relationship to XC's Other Interspinous Spacer

Rather than assuming this is either a duplicate or an unrelated product, this page presents the naming and design overlap directly, helping procurement teams confirm the correct reference with Medigear.uk before ordering.

ISO 13485-Certified Manufacturing for Procurement Governance

XC's quality management system is certified to ISO 13485 at company level, giving hospital procurement teams and distributors a documented baseline to evaluate against tender requirements. Buyers should confirm CE marking status for this specific reference before submitting to formal procurement processes.

Titanium Construction

The device is manufactured from titanium, consistent with the biocompatibility and radiopacity generally associated with implantable spinal devices in clinical literature.

REF-Coded Ordering for Simplified Procurement

Each size is ordered under its own REF code, giving procurement teams a clear, unambiguous way to specify the exact device needed against a surgeon's preoperative plan.

Small-Batch Ordering for Specialist Clinics and Independent Practices

Independent spine surgeons and smaller private surgical centres do not always need trust-scale order volumes, and Medigear.uk supports single or small-quantity purchasing of this device alongside its larger distributor accounts.

8mm and 9mm Sizes

The two smallest confirmed sizes, separated by a 1mm step.

10mm Size

Confirmed at the boundary between the finer 1mm steps and the wider 2mm steps in this reference's size pattern.

12mm and 14mm Sizes

The largest confirmed sizes, in 2mm steps.

Titanium Construction

Manufactured from titanium, consistent with general interspinous spacer device design.

REF-Coded Ordering System

Each size carries its own REF code, providing a clear, unambiguous way to specify the exact device needed for a given order.

Distinct REF Prefix from XC's Other Interspinous Spacer

Carries the UJT prefix, distinct from the KTJT prefix confirmed on a separate, identically named product in this catalogue.

Visually Distinct Pictured Design

The hardware pictured for this reference differs visually from the other confirmed interspinous spacer product, though the exact functional or anatomical rationale for this difference has not been confirmed.

Extension-Blocking Mechanism

General literature describes this device category as limiting spinal extension at the treated level, indirectly decompressing the neural foramina and central canal.

Distinct Product Category from XC's Fusion and Interbody Devices

Implanted between adjacent spinous processes rather than within the disc space or in place of a vertebral body, a genuinely different clinical application from other products in this catalogue.

Relationship to Companion Product Unresolved

Whether this reference and XC's other identically named interspinous spacer are distinct designs or inconsistently documented duplicates has not been confirmed and should be checked with Medigear.uk.

Minimally Invasive Implantation Technique

General literature describes this device category as suited to minimally invasive implantation, in some cases under local anaesthesia.

Five Confirmed Sizes Across an Irregular Graduation

From 8mm to 14mm, giving procurement teams a confirmed range with finer steps at the smaller end than XC's other interspinous spacer product.

The XC Interspinous Spacer (Titanium), REF prefix UJT, is a minimally invasive device confirmed across five sizes (8mm to 14mm), designed for indirect decompression of lumbar spinal stenosis. It shares its product name exactly with a separate confirmed XC product under a different REF prefix, KTJT, and the relationship between the two, whether distinct designs or inconsistently documented duplicates, has not been resolved and should be raised directly with Medigear.uk. It suits patients with neurogenic claudication who have not responded to conservative care, patients with significant comorbidities, and cases requiring finer size graduation at the smaller end of the range. XC's ISO 13485-certified manufacturing gives procurement teams a documented baseline for evaluation. A substantial general clinical literature base supports the interspinous spacer device category broadly. However, confirm the CE marking status, outcome data specific to this exact XC reference, and the relationship to XC's other interspinous spacer product with Medigear.uk before tender. Contact Medigear.uk for specifications, procurement assistance, or expert consultation.